Identification of novel and orally active spiroindoline NPY Y5 receptor antagonists

被引:17
作者
Sakamoto, Toshihiro [1 ]
Moriya, Minoru [1 ]
Haga, Yuji [1 ]
Takahashi, Toshiyuki [1 ]
Shibata, Takunobu [1 ]
Okamoto, Osamu [1 ]
Nonoshita, Katsumasa [1 ]
Kitazawa, Hidefumi [1 ]
Hidaka, Masayasu [1 ]
Gomori, Akira [1 ]
Iwaasa, Hisashi [1 ]
Ishihara, Akane [1 ]
Kanatani, Akio [1 ]
Fukami, Takehiro [1 ]
Gao, Ying-Duo [2 ]
MacNeil, Douglas J. [2 ]
Yang, Lihu [2 ]
机构
[1] Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan
[2] Merck Res Labs, Rahway, NJ 07065 USA
关键词
NPY; Neuropeptide Y; Y5; receptor; Antagonist; Obesity; NEUROPEPTIDE YY5 RECEPTOR; PANCREATIC-POLYPEPTIDE; PEPTIDE-YY; POTENT ANTAGONISTS; Y1; RECEPTOR; FUNCTIONAL EXPRESSION; FEEDING-BEHAVIOR; FOOD-INTAKE; HYDRAZIDE DERIVATIVES; HIGH-AFFINITY;
D O I
10.1016/j.bmcl.2009.02.035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of spiroindoline-3,40-piperidine derivatives were synthesized and evaluated for their binding affinities and antagonistic activities at Y5 receptors. Potent Y5 antagonists were tested for their oral bioavailabilities and brain penetration in rats. Some of the antagonists showed good oral bioavailability and/ or good brain penetration. In particular, compound 6e was orally bioavailable and brain penetrant, and oral administration of 6e inhibited bPP-induced food intake in rats with a minimum effective dose of 10 mg/ kg. (C) 2009 Published by Elsevier Ltd.
引用
收藏
页码:1564 / 1568
页数:5
相关论文
共 61 条
[1]   Synthesis and structure activity relationship of guanidines as NPYY5 antagonists [J].
Aquino, CJ ;
Ramanjulu, JM ;
Heyer, D ;
Daniels, AJ ;
Palazzo, F ;
Dezube, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (10) :2691-2708
[2]   CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN Y4 SUBTYPE RECEPTOR FOR PANCREATIC-POLYPEPTIDE, NEUROPEPTIDE-Y, AND PEPTIDE YY [J].
BARD, JA ;
WALKER, MW ;
BRANCHEK, TA ;
WEINSHANK, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :26762-26765
[3]   Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity [J].
Block, MH ;
Boyer, S ;
Brailsford, W ;
Brittain, DR ;
Carroll, D ;
Chapman, S ;
Clarke, DS ;
Donald, CS ;
Foote, KM ;
Godfrey, L ;
Ladner, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (16) :3509-3523
[4]   NEUROPEPTIDE-Y AND HUMAN PANCREATIC-POLYPEPTIDE STIMULATE FEEDING-BEHAVIOR IN RATS [J].
CLARK, JT ;
KALRA, PS ;
CROWLEY, WR ;
KALRA, SP .
ENDOCRINOLOGY, 1984, 115 (01) :427-429
[5]   HIGH-AFFINITY NEUROPEPTIDE-Y RECEPTOR ANTAGONISTS [J].
DANIELS, AJ ;
MATTHEWS, JE ;
SLEPETIS, RJ ;
JANSEN, M ;
VIVEROS, OH ;
TADEPALLI, A ;
HARRINGTON, W ;
HEYER, D ;
LANDAVAZO, A ;
LEBAN, JJ ;
SPALTENSTEIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9067-9071
[6]   Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists [J].
Elliott, RL ;
Oliver, RM ;
LaFlamme, JA ;
Gillaspy, ML ;
Hammond, M ;
Hank, RF ;
Maurer, TS ;
Baker, DL ;
DaSilva-Jardine, PA ;
Stevenson, RW ;
Mack, CM ;
Cassella, JV .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) :3593-3596
[7]   In vitro and in vivo characterization of 3-{2-[6-(2-tert-butoxyethoxy)pyridin-3-yl}-1H-imidazol-4-yl}benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist [J].
Elliott, RL ;
Oliver, RM ;
Hammond, M ;
Patterson, TA ;
She, L ;
Hargrove, DM ;
Martin, KA ;
Maurer, TS ;
Kalvass, JC ;
Morgan, BP ;
DaSilva-Jardine, PA ;
Stevenson, RW ;
Mack, CM ;
Cassella, JV .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (05) :670-673
[8]   THE MURINE NPY-1 RECEPTOR GENE - STRUCTURE AND DELINEATION OF TISSUE-SPECIFIC EXPRESSION [J].
EVA, C ;
OBERTO, A ;
SPRENGEL, R ;
GENAZZANI, E .
FEBS LETTERS, 1992, 314 (03) :285-288
[9]   High-throughput synthesis optimization of sulfonamide NPYY5 antagonists [J].
Finn, J ;
Pelham, D ;
Walker, MW ;
Gluchowski, C .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (13) :1771-1774
[10]   Synthesis and structure-activity relationships of trisubstituted phenyl urea derivatives as neuropeptide Y5 receptor antagonists [J].
Fotsch, C ;
Sonnenberg, JD ;
Chen, N ;
Hale, C ;
Karbon, W ;
Norman, MH .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (14) :2344-2356